2008
DOI: 10.1016/j.exphem.2008.03.016
|View full text |Cite
|
Sign up to set email alerts
|

AMD3100 synergizes with G-CSF to mobilize repopulating stem cells in Fanconi anemia knockout mice

Abstract: Fanconi anemia (FA) is a heterogeneous inherited disorder characterized by a progressive bone marrow (BM) failure and susceptibility to myeloid leukemia. Genetic correction using gene transfer technology is one potential therapy. A major hurdle in applying this technology in FA patients is the inability of granulocyte colony-stimulating factor (G-CSF) to mobilize sufficient numbers of hematopoietic stem (HSC)/progenitor cells (HPC) from the BM to the PB. Whether the low number of CD34 + cells is a result of BM… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1

Citation Types

0
23
0

Year Published

2009
2009
2021
2021

Publication Types

Select...
7
2

Relationship

0
9

Authors

Journals

citations
Cited by 34 publications
(23 citation statements)
references
References 45 publications
(32 reference statements)
0
23
0
Order By: Relevance
“…Doses of 5 to 10 mg/kg are routinely administered to adult mice for acute mobilization of hematopoietic progenitor cells. 28,43,44 BecauseAMD3100 has a short half-life in vivo (3.6 hours in healthy humans 45 ), an increased dose was used to antagonize CXCR4 activity long enough to effect a change in the developing retinal vasculature. Although AMD3100 has been reported to be highly specific to CXCR4, a recent report suggests that it may also bind the other known SDF-1 receptor, CXCR7.…”
Section: Discussionmentioning
confidence: 99%
“…Doses of 5 to 10 mg/kg are routinely administered to adult mice for acute mobilization of hematopoietic progenitor cells. 28,43,44 BecauseAMD3100 has a short half-life in vivo (3.6 hours in healthy humans 45 ), an increased dose was used to antagonize CXCR4 activity long enough to effect a change in the developing retinal vasculature. Although AMD3100 has been reported to be highly specific to CXCR4, a recent report suggests that it may also bind the other known SDF-1 receptor, CXCR7.…”
Section: Discussionmentioning
confidence: 99%
“…hematopoietic progenitor stem cells (from the femoral bone marrow) in mice and humans [30]; and hematopoietic stem cells in Fanconi anemia knockout mice [31].…”
Section: Page 7 Of 30mentioning
confidence: 99%
“…Furthermore, patients receiving G-CSF-mobilized PBSCs have an increased incidence of chronic graft-versus-host disease (GVHD) following allogeneic transplantation (8). In addition, because older individuals or patients with Fanconi anemia (FA) show poor HSPC mobilization in response to G-CSF (9,10), it is necessary to tailor mobilization regimens to the individual clinical situation. Patients whose bone marrow has been damaged by extensive chemotherapy and radiation therapy also respond poorly to conventional mobilization regimens.…”
Section: Introductionmentioning
confidence: 99%